within Pharmacolibrary.Drugs.ATC.G;

model G01AF11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.37,
    Cl             = 0.028333333333333332,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.00041999999999999996,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.022833333333333334,
    Tlag           = 900
  );

  annotation(Documentation(
    info ="<html><body><p>Ketoconazole is an imidazole antifungal medication primarily used to treat fungal infections of the skin and mucous membranes. It was also formerly used systemically for treatment of severe fungal infections, but oral use has been substantially restricted in many countries due to risk of severe hepatic toxicity. Topical preparations remain in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following single oral administration.</p><h4>References</h4><ol><li><p>DeVane, CL, &amp; Nemeroff, CB (2001). Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. <i>Clinical pharmacokinetics</i> 40(7) 509–522. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200140070-00003&quot;>10.2165/00003088-200140070-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11510628/&quot;>https://pubmed.ncbi.nlm.nih.gov/11510628</a></p></li><li><p>KuKanich, B, et al., &amp; Black, J (2017). The effects of ketoconazole and cimetidine on the pharmacokinetics of oral tramadol in greyhound dogs. <i>Journal of veterinary pharmacology and therapeutics</i> 40(6) e54–e61. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12424&quot;>10.1111/jvp.12424</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28603935/&quot;>https://pubmed.ncbi.nlm.nih.gov/28603935</a></p></li><li><p>Abbas, R, et al., &amp; Sonnichsen, D (2011). Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects. <i>British journal of clinical pharmacology</i> 71(4) 522–527. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.2010.03845.x&quot;>10.1111/j.1365-2125.2010.03845.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21395644/&quot;>https://pubmed.ncbi.nlm.nih.gov/21395644</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G01AF11;
